The effects of glutamine/asparagine content on aggregation and heterologous prion induction by yeast prion-like domains

被引:13
|
作者
Shattuck, Jenifer E. [1 ]
Waechter, Aubrey C. [1 ]
Ross, Eric D. [1 ]
机构
[1] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA
基金
美国国家科学基金会;
关键词
yeast; prion; amyloid; protein aggregation; prion-like domains; PSI+ PRION; SEQUENCE FEATURES; PHASE-TRANSITION; LIQUID DROPLETS; PROTEINS; GRANULES; COMPLEXITY; PREDICTION; FORM; RICH;
D O I
10.1080/19336896.2017.1344806
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion-like domains are low complexity, intrinsically disordered domains that compositionally resemble yeast prion domains. Many prion-like domains are involved in the formation of either functional or pathogenic protein aggregates. These aggregates range from highly dynamic liquid droplets to highly ordered detergent-insoluble amyloid-like aggregates. To better understand the amino acid sequence features that promote conversion to stable, detergent-insoluble aggregates, we used the prediction algorithm PAPA to identify predicted aggregation-prone prion-like domains with a range of compositions. While almost all of the predicted aggregation-prone domains formed foci when expressed in cells, the ability to form the detergent-insoluble aggregates was highly correlated with glutamine/asparagine (Q/N) content, suggesting that high Q/N content may specifically promote conversion to the amyloid state in vivo. We then used this data set to examine cross-seeding between prion-like proteins. The prion protein Sup35 requires the presence of a second prion, [PIN+], to efficiently form prions, but this requirement can be circumvented by the expression of various Q/N-rich protein fragments. Interestingly, almost all of the Q/N-rich domains that formed SDS-insoluble aggregates were able to promote prion formation by Sup35, highlighting the highly promiscuous nature of these interactions.
引用
收藏
页码:249 / 264
页数:16
相关论文
共 50 条
  • [21] Prion-like strain effects in tauopathies
    Han, Zhuang Zhuang
    Kang, Sang-Gyun
    Arce, Luis
    Westaway, David
    CELL AND TISSUE RESEARCH, 2023, 392 (01) : 179 - 199
  • [22] Prion-like Domains Program Ewing's Sarcoma
    Shorter, James
    CELL, 2017, 171 (01) : 30 - 31
  • [23] Phase behavior of intrinsically disordered prion-like domains
    Mittag, Tanja
    Bremer, Anne
    Farag, Mina
    Borcherds, Wade M.
    Pappu, Rohit V.
    FASEB JOURNAL, 2022, 36
  • [24] Characterization of the interaction domains of Ure2p, a prion-like protein of yeast
    Fernandez-Bellot, Eric
    Guillemet, Elisabeth
    Baudin-Baillieu, Agnes
    Gaumer, Sebastien
    Komar, Anton A.
    Cullin, Christophe
    Biochemical Journal, 1999, 338 (1-2): : 403 - 407
  • [25] Manipulating the aggregation activity of human prion-like proteins
    Cascarina, Sean M.
    Paul, Kacy R.
    Ross, Eric D.
    PRION, 2017, 11 (05) : 323 - 331
  • [26] Characterization of the interaction domains of Ure2p, a prion-like protein of yeast
    Fernandez-Bellot, E
    Guillemet, E
    Baudin-Baillieu, A
    Gaumer, S
    Komar, AA
    Cullin, C
    BIOCHEMICAL JOURNAL, 1999, 338 : 403 - 407
  • [27] Prion-like protein aggregation of desmin myofibrillar myopathies
    Weihl, C.
    Bieschke, J.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S247 - S248
  • [28] Overproduction of proteins with prion-like domains can cure cells of the [PSI+] prion.
    Bagriantsev, S
    Hong, J
    Derkatch, I
    Liebman, S
    YEAST, 2003, 20 : S325 - S325
  • [29] Investigation of RNA-binding proteins with prion-like domains
    Boncella, Amy
    Watkins, Brittani
    Ross, Eric
    PRION, 2015, 9 : S54 - S54
  • [30] Interaction Networks of Prion, Prionogenic and Prion-Like Proteins in Budding Yeast, and Their Role in Gene Regulation
    Harbi, Djamel
    Harrison, Paul M.
    PLOS ONE, 2014, 9 (06):